HN

Hemmige Narayana Srimathi

Active Director Director DIN 11286471
DIN 11286471 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemmige Narayana Srimathi

Data last updated:

Hemmige Narayana Srimathi is a Director at Nivaris Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11286471
Primary Designation Director
Industry Healthcare
First Appointment 08 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nivaris Healthcare Private Limited U62099KA2025PTC208031
Director08 Sep 20252025Active

Board colleagues of Hemmige Narayana Srimathi

NameDINCompanyDesignation
Shilpa Sharad11286472Nivaris Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nivaris Healthcare Private Limited
Premium access

Shareholding and investment profile for Hemmige Narayana Srimathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemmige Narayana Srimathi

Hemmige Narayana Srimathi currently holds 1 directorship: Nivaris Healthcare Private Limited (Director, since 08 Sep 2025).

Hemmige Narayana Srimathi was first appointed on 08 Sep 2025 as Director at Nivaris Healthcare Private Limited.

The current boards of Hemmige Narayana Srimathi's companies include Shilpa Sharad (Nivaris Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available